Hormonal Contraceptive Market

Hormonal Contraceptive Market (Method: Oral Contraceptives, Transdermal Patches, Injectable Contraceptives, Intrauterine Contraceptives, and Vaginal Rings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031

Hormonal Contraceptive Market Outlook 2031

  • The global industry was valued at US$ 21.8 Bn in 2022
  • It is estimated to grow at a CAGR of 5.0% from 2023 to 2031 and reach US$ 33.8 Bn by the end of 2031

Analyst Viewpoint

Increase in awareness about sex education and reproductive wellness is a primary factor contributing to the hormonal contraceptive market growth.

Rise in family planning decisions, especially in the urban landscape, is also augmenting market trajectory.

Surge in the number of e-commerce platforms is another factor bolstering the hormonal contraceptive industry size. Online platforms offer easy access to contraceptives and other sexual wellness products, thus helping tackle societal stigma while ensuring safety and overall emotional wellbeing for women.

Prominent players in the global hormonal contraceptive market are investing substantially in advancements in low-dosage alternatives and innovative hormone release and delivery mechanisms to better cater to evolving consumer preferences.

Market Introduction

Hormonal contraceptives are specialized drugs that consist of synthetic hormones such as estrogen and progestin that prevent pregnancy.Hormone-based contraceptives are available in several forms including oral pills, patches, injections, and vaginal rings.

Recent hormonal contraceptive market trends indicate an enhanced focus on women’s safety, emotional health, and reduced side effects.Pharmaceutical firms are experimenting with lower hormone dosages such as ultra-low dose oral pills and intrauterine devices (IUDs) with localized hormone delivery mechanisms.

Additionally, innovations in hormone release and delivery mechanisms with products such as vaginal rings and digital health solutions are gaining traction to make reproductive health more effective and accessible.

Attribute Detail
Market Drivers
  • Rise in Awareness about Sex Education and Reproductive Health
  • Expansion in E-commerce Sector

Increase in Awareness about Sex Education and Reproductive Health Boosting Hormonal Contraceptive Market Statistics

Awareness about sex education and reproductive wellness is essential for good decision-making during family planning.

Governments, education boards, and NGOs play a collaborative and crucial role in educating the youth and the general public by offering accessible resources and conducting workshops and awareness campaigns to foster positive attitude around sexuality, reproductive health, and relationships.

The Government of India’s Ministry of Health and Family Welfare allocated about INR 342.5 Cr (US$ 42.0 Mn) for family planning and reproductive health wellness awareness campaigns in 2021.

The Government of Canada has a decade-long commitment to fund US$ 1.4 Bn annually for public initiatives around women and children's health. Around US$ 700.0 Mn of this funding is targeted toward sexual and reproductive health and rights.

Empowered individuals who make conscious choices based on accurate information are literate about contraceptives and have a high chance of adopting hormonal contraceptives, thus advancing the hormonal contraceptives market demand.

Expansion in E-commerce Sector Fueling Market Progress

In recent times, there has been a surge in online shopping platforms or e-commerce websites or apps due to the rising inclination toward convenience and comfort-based purchasing among modern consumers.

E-commerce platforms offer a discreet and easy way for individuals to search, choose, and buy a variety of products, including hormonal contraceptives such as injectables, oral pills, and patches.

They also assist in navigating the stigma around sexuality. Awareness and accessibility to steroidal contraceptives and birth control is likely to increase, as more hormonal drugs get approval to be bought over-the-counter. This is projected to foster hormonal contraceptive market expansion.

According to a survey conducted by KKF, a health policy advocacy group, most young people buy contraceptives online owing to the ease of access and mitigation of the risk of stigma. Most people who buy contraceptives online are in the age group of 18-25 (32%) and 26-35 (46%).

Regional Outlook

Attribute Detail
Leading Region North America

North America held the largest hormonal contraceptive market share in 2022. Rise in awareness around sexual wellness and reproductive health, and the presence of robust healthcare infrastructure are augmenting the market growth of the region.

According to a report by the Centers for Disease Control and Prevention (CDC), in 2020, 620,327 legal abortions occurred across 47 states of the U.S. The report also states that nearly 45% of the teenage population in the U.S. is sexually active and in need of contraceptives.

The hormonal contraceptive industry in Europe is projected to grow at a steady pace from 2023 to 2031. Progressive government initiatives and access to public healthcare are some of the factors propelling hormonal contraceptive market dynamics of the region.

Analysis of Key Players

Prominent manufacturers operating in the hormonal contraceptive market are investing in the development of birth control patches and reproductive hormone inhibitors to cater to a consumer base that is highly aware of their reproductive health.

Constant product innovation via collaborations with other players and mergers & acquisitions are key strategies employed by the leading players in the global hormonal contraceptive landscape.

AbbVie, Inc., Afaxys, Inc., Bayer AG, Agile Therapeutics, Merck & Co., Inc., Piramal Enterprises Ltd., Pfizer Inc., HLL Lifecare Limited are the prominent companies operating in the worldwide market.

The hormonal contraceptive market report highlights parameters such as business strategies, company overview, product portfolio, financial overview, and business segments of these companies.

Key Developments

  • In December 2023, researchers in the U.K. initiated the first-ever clinical trial for a non-hormonal male birth control pill, with 16 participants. The study and potential commercialization of the drug aim to minimize the gap that exists between the availability of contraception for the two genders.
  • In July 2022, Mayne Pharma Group Limited and Mithra Pharmaceuticals, SA introduced NEXTSTELLIS, an innovative oral contraceptive that includes a unique estrogen formulation combining drospirenone (14.2 mg estetrol and 3 mg drospirenone tablets). This collaboration is one of the first such products available in Australia.

Hormonal Contraceptive Market Snapshot

Attribute Detail
Market Value in 2022 (Base Year) US$ 21.8 Bn
Market Forecast Value in 2031 US$ 33.8 Bn
Growth Rate (CAGR) 5.0%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis.
Competition Landscape
  • Prominent Players – Competition Dashboard and Revenue Share Analysis, 2022
  • Company Profiles (Details – Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
Format Electronic (PDF) + Excel
Market Segmentation
  • Method
    • Oral Contraceptives
    • Transdermal Patches
    • Injectable Contraceptives
    • Intrauterine Contraceptives
    • Vaginal Rings
  • Hormones
    • Progestin Only
    • Combined Hormones
  • Distribution Channel
    • Drug Stores
    • Gynecology/Fertility Clinics
    • E-commerce
    • Others
Regions Covered
  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • AbbVie, Inc.
  • Afaxys, Inc.
  • Bayer AG
  • Agile Therapeutics
  • Merck & Co., Inc.
  • Piramal Enterprises Ltd.
  • Pfizer Inc.
  • HLL Lifecare Limited
Customization Scope Available upon Request
Pricing Available upon Request

Frequently Asked Questions

How big was the global hormonal contraceptive market in 2022?

It was valued at US$ 21.8 Bn in 2022

How is the hormonal contraceptive business expected to grow by 2031?

It is projected to grow at a CAGR of 5.0% from 2023 to 2031

What are the key factors driving the demand for hormonal contraceptive?

Rise in awareness about sex education and reproductive health, and expansion in e-commerce sector

Which was the major region in the global hormonal contraceptive industry in 2022?

North America dominated the global landscape in 2022

Who are the key hormonal contraceptive manufacturers?

AbbVie, Inc., Afaxys, Inc., Bayer AG, Agile Therapeutics, Merck & Co., Inc., Piramal Enterprises Ltd., Pfizer Inc., HLL Lifecare

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Hormonal Contraceptive Market

4. Market Overview

    4.1. Introduction

        4.1.1. Technology Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Hormonal Contraceptive Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Technology/Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. Hormonal Contraceptive Market Analysis and Forecast, by Method

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Method, 2017–2031

        6.3.1. Oral Contraceptives

        6.3.2. Transdermal Patches

        6.3.3. Injectable Contraceptives

        6.3.4. Intrauterine Contraceptives

        6.3.5. Vaginal Rings

    6.4. Market Attractiveness Analysis, by Method

7. Hormonal Contraceptive Market Analysis and Forecast, by Hormones

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Hormones, 2017–2031

        7.3.1. Progestin Only

        7.3.2. Combined Hormones

    7.4. Market Attractiveness Analysis, by Hormones

8. Hormonal Contraceptive Market Analysis and Forecast, by Distribution Channel

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by Distribution Channel, 2017–2031

        8.3.1. Drug Stores

        8.3.2. Gynecology/Fertility Clinics

        8.3.3. E-commerce

        8.3.4. Others

    8.4. Market Attractiveness Analysis, by Hormones

9. Hormonal Contraceptive Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region, 2017–2031

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Hormonal Contraceptive Market Analysis and Forecast

    10.1. Introduction

    10.2. Key Findings

    10.3. Market Value Forecast, by Method, 2017–2031

        10.3.1. Oral Contraceptives

        10.3.2. Transdermal Patches

        10.3.3. Injectable Contraceptives

        10.3.4. Intrauterine Contraceptives

        10.3.5. Vaginal Rings

    10.4. Market Value Forecast, by Hormones, 2017–2031

        10.4.1. Progestin Only

        10.4.2. Combined Hormones

    10.5. Market Value Forecast, by Distribution Channel, 2017–2031

        10.5.1. Drug Stores

        10.5.2. Gynecology/Fertility Clinics

        10.5.3. E-commerce

        10.5.4. Others

    10.6. Market Value Forecast, by Country, 2017–2031

        10.6.1. U.S.

        10.6.2. Canada

    10.7. Market Attractiveness Analysis

        10.7.1. By Method

        10.7.2. By Hormones

        10.7.3. By Distribution Channel

        10.7.4. By Country

11. Europe Hormonal Contraceptive Market Analysis and Forecast

    11.1. Introduction

    11.2. Key Findings

    11.3. Market Value Forecast, by Method, 2017–2031

        11.3.1. Oral Contraceptives

        11.3.2. Transdermal Patches

        11.3.3. Injectable Contraceptives

        11.3.4. Intrauterine Contraceptives

        11.3.5. Vaginal Rings

    11.4. Market Value Forecast, by Hormones, 2017–2031

        11.4.1. Progestin Only

        11.4.2. Combined Hormones

    11.5. Market Value Forecast, by Distribution Channel, 2017–2031

        11.5.1. Drug Stores

        11.5.2. Gynecology/Fertility Clinics

        11.5.3. E-commerce

        11.5.4. Others

    11.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.6.1. Germany

        11.6.2. U.K.

        11.6.3. France

        11.6.4. Italy

        11.6.5. Spain

        11.6.6. Rest of Europe

    11.7. Market Attractiveness Analysis

        11.7.1. By Method

        11.7.2. By Hormones

        11.7.3. By Distribution Channel

        11.7.4. By Country/Sub-region

12. Asia Pacific Hormonal Contraceptive Market Analysis and Forecast

    12.1. Introduction

    12.2. Key Findings

    12.3. Market Value Forecast, by Method, 2017–2031

        12.3.1. Oral Contraceptives

        12.3.2. Transdermal Patches

        12.3.3. Injectable Contraceptives

        12.3.4. Intrauterine Contraceptives

        12.3.5. Vaginal Rings

    12.4. Market Value Forecast, by Hormones, 2017–2031

        12.4.1. Progestin Only

        12.4.2. Combined Hormones

    12.5. Market Value Forecast, by Distribution Channel, 2017–2031

        12.5.1. Drug Stores

        12.5.2. Gynecology/Fertility Clinics

        12.5.3. E-commerce

        12.5.4. Others

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.6.1. China

        12.6.2. Japan

        12.6.3. India

        12.6.4. Australia & New Zealand

        12.6.5. Rest of Asia Pacific

    12.7. Market Attractiveness Analysis

        12.7.1. By Method,

        12.7.2. By Hormones

        12.7.3. By Distribution Channel

        12.7.4. By Country/Sub-region

13. Latin America Hormonal Contraceptive Market Analysis and Forecast

    13.1. Introduction

    13.2. Key Findings

    13.3. Market Value Forecast, by Method, 2017–2031

        13.3.1. Oral Contraceptives

        13.3.2. Transdermal Patches

        13.3.3. Injectable Contraceptives

        13.3.4. Intrauterine Contraceptives

        13.3.5. Vaginal Rings

    13.4. Market Value Forecast, by Hormones, 2017–2031

        13.4.1. Progestin Only

        13.4.2. Combined Hormones

    13.5. Market Value Forecast, by Distribution Channel, 2017–2031

        13.5.1. Drug Stores

        13.5.2. Gynecology/Fertility Clinics

        13.5.3. E-commerce

        13.5.4. Others

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.6.1. Brazil

        13.6.2. Mexico

        13.6.3. Rest of Latin America

    13.7. Market Attractiveness Analysis

        13.7.1. By Method,

        13.7.2. By Hormones

        13.7.3. By Distribution Channel

        13.7.4. By Country/Sub-region

14. Middle East & Africa Hormonal Contraceptive Market Analysis and Forecast

    14.1. Introduction

    14.2. Key Findings

    14.3. Market Value Forecast, by Method, 2017–2031

        14.3.1. Oral Contraceptives

        14.3.2. Transdermal Patches

        14.3.3. Injectable Contraceptives

        14.3.4. Intrauterine Contraceptives

        14.3.5. Vaginal Rings

    14.4. Market Value Forecast, by Hormones, 2017–2031

        14.4.1. Progestin Only

        14.4.2. Combined Hormones

    14.5. Market Value Forecast, by Distribution Channel, 2017–2031

        14.5.1. Drug Stores

        14.5.2. Gynecology/Fertility Clinics

        14.5.3. E-commerce

        14.5.4. Others

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.6.1. GCC Countries

        14.6.2. South Africa

        14.6.3. Rest of Middle East & Africa

    14.7. Market Attractiveness Analysis

        14.7.1. By Method,

        14.7.2. By Hormones

        14.7.3. By Distribution Channel

        14.7.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

    15.2. Market Share Analysis, by Company (2022)

    15.3. Company Profiles

        15.3.1. AbbVie, Inc.

            15.3.1.1. Company Overview

            15.3.1.2. Technology, Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Financial Overview

            15.3.1.5. Strategic Overview

        15.3.2. Afaxys, Inc.

            15.3.2.1. Company Overview

            15.3.2.2. Technology, Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Financial Overview

            15.3.2.5. Strategic Overview

        15.3.3. Bayer AG

            15.3.3.1. Company Overview

            15.3.3.2. Technology, Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Financial Overview

            15.3.3.5. Strategic Overview

        15.3.4. Agile Therapeutics

            15.3.4.1. Company Overview

            15.3.4.2. Technology, Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Financial Overview

            15.3.4.5. Strategic Overview

        15.3.5. Merck & Co., Inc.

            15.3.5.1. Company Overview

            15.3.5.2. Technology, Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Financial Overview

            15.3.5.5. Strategic Overview

        15.3.6. Piramal Enterprises Ltd.

            15.3.6.1. Company Overview

            15.3.6.2. Technology, Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Financial Overview

            15.3.6.5. Strategic Overview

        15.3.7. Pfizer Inc.

            15.3.7.1. Company Overview

            15.3.7.2. Technology, Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Financial Overview

            15.3.7.5. Strategic Overview

        15.3.8. HLL Lifecare Limited

            15.3.8.1. Company Overview

            15.3.8.2. Technology, Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Financial Overview

            15.3.8.5. Strategic Overview

List of Tables

Table 01: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017–2031

Table 02: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017–2031

Table 03: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 04: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017–2031

Table 07: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017–2031

Table 08: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 09: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017–2031

Table 11: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017–2031

Table 12: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 13: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017–2031

Table 15: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017–2031

Table 16: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 17: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017–2031

Table 19: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017–2031

Table 20: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 21: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017–2031

Table 23: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017–2031

Table 24: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

List of Figures

Figure 01: Hormonal Contraceptive Market Size (US$ Mn) and Distribution (%), by Region, 2017–2031

Figure 02: Hormonal Contraceptive Market Revenue (US$ Mn), by Method, 2022

Figure 03: Hormonal Contraceptive Market Value Share, by Method, 2022

Figure 04: Hormonal Contraceptive Market Revenue (US$ Mn), by Hormones, 2022

Figure 05: Hormonal Contraceptive Market Value Share, by Hormones, 2022

Figure 06: Hormonal Contraceptive Market Revenue (US$ Mn), by Distribution Channel, 2022

Figure 07: Hormonal Contraceptive Market Value Share, by Distribution Channel, 2022

Figure 08: Hormonal Contraceptive Market Value Share, by Region, 2022

Figure 09: Hormonal Contraceptive Market Value (US$ Mn) Forecast, 2017–2031

Figure 10: Hormonal Contraceptive Market Value Share Analysis, by Method, 2017–2031

Figure 11: Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017–2031

Figure 12: Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017–2031

Figure 13: Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017–2031

Figure 14: Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 15: Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017–2031

Figure 16: Hormonal Contraceptive Market Value Share Analysis, by Region, 2017–2031

Figure 17: Hormonal Contraceptive Market Attractiveness Analysis, by Region, 2017–2031

Figure 18: North America Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 19: North America Hormonal Contraceptive Market Attractiveness Analysis, by Country, 2017–2031

Figure 20: North America Hormonal Contraceptive Market Value Share Analysis, by Country, 2017–2031

Figure 21: North America Hormonal Contraceptive Market Value Share Analysis, by Method, 2017–2031

Figure 22: North America Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017–2031

Figure 23: North America Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 24: North America Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017–2031

Figure 25: North America Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017–2031

Figure 26:North America Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017–2031

Figure 27: Europe Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 28: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 29: Europe Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017–2031

Figure 30: Europe Hormonal Contraceptive Market Value Share Analysis, by Method, 2017–2031

Figure 31: Europe Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017–2031

Figure 32: Europe Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 33: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017–2031

Figure 34: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017–2031

Figure 35: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017–2031

Figure 36: Asia Pacific Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 37: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 38: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017–2031

Figure 39: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Method, 2017–2031

Figure 40: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017–2031

Figure 41: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 42: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017–2031

Figure 43: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017–2031

Figure 44: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017–2031

Figure 45: Latin America Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 46: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 47: Latin America Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017–2031

Figure 48: Latin America Hormonal Contraceptive Market Value Share Analysis, by Method, 2017–2031

Figure 49: Latin America Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017–2031

Figure 50: Latin America Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 51: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017–2031

Figure 52: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017–2031

Figure 53: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017–2031

Figure 54: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 55: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 56: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017–2031

Figure 57: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Method, 2017–2031

Figure 58: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017–2031

Figure 59: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 60: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017–2031

Figure 61: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017–2031

Figure 62: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017–2031

Copyright © Transparency Market Research, Inc. All Rights reserved